Ani Pharmaceuticals (ANIP) EPS (Basic) (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted EPS (Basic) of $1.41 for Q1 2026, up 2.87% sequentially from $1.37 in Q4 2025, and up 81.01% YoY from $0.78 in Q1 2025.
Ani Pharmaceuticals (ANIP) EPS (Basic) (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported EPS (Basic) for 16 years, with the latest figure at $1.41 in Q1 2026.
- Quarterly EPS (Basic) rose 81.01% year-over-year to $1.41 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.37 (up 477.92% YoY) and the FY2025 annual result came in at $3.85, up 469.04% from the prior year.
- EPS (Basic) advanced to $1.41 in Q1 2026 per ANIP's latest filing, from $1.37 in the prior quarter.
- Over five years, EPS (Basic) peaked at $1.41 in Q1 2026 and troughed at -$1.27 in Q1 2022.
- A 5-year average of $0.13 and a median of $0.06 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 18958.75% in 2022, then surged 1378.99% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.29 in 2022, then jumped by 114.55% to $0.04 in 2023, then slumped by 1428.94% to -$0.55 in 2024, then jumped by 347.92% to $1.37 in 2025, then rose by 2.87% to $1.41 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $1.41, $1.37, and $1.31 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 1.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 |
| Mar 31, 2026 | 1.41 |
| Dec 31, 2025 | 1.37 |
| Sep 30, 2025 | 1.31 |
| Jun 30, 2025 | 0.41 |
| Mar 31, 2025 | 0.78 |
| Dec 31, 2024 | -0.55 |
| Sep 30, 2024 | -1.27 |
| Jun 30, 2024 | -0.14 |
| Mar 31, 2024 | 0.93 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.50 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | -0.29 |
| Sep 30, 2022 | -0.55 |
| Jun 30, 2022 | -0.94 |
| Mar 31, 2022 | -1.27 |
| Dec 31, 2021 | -1.93 |
| Sep 30, 2021 | -0.37 |